Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...
People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...
Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...
Hims & Hers Health put out a jaw dropping commercial. Now, Hims stock is just dropping, as its semaglutide business faces a ...
Medical treatments, including jabs used for weight loss, are monitored in part using the Medicines and Healthcare products ...
It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...
Patients report that GLP-1 drugs like Ozempic and Mounjaro reduce “food noise,” the constant mental chatter about eating.
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug ...
Ozempic, and its GLP-1 cousins Mounjaro ... PricewaterhouseCoopers sees upsides in fitness in this group — 35 percent of weight-loss drug users PwC surveyed said they are exercising for the ...
Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...